Home » Drug Makers to Settle Adalat Suit
Drug Makers to Settle Adalat Suit
A California judge has approved a settlement that could see Mississauga drug maker Biovail and two other pharmaceutical companies pay out $8.2 million (U.S.) to settle antitrust claims over the hypertension drug Adalat.
The Mississauga News
Upcoming Events
-
07May
-
14May
-
30May